3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
139
Carcinoma, Intraductal, Noninfiltrating
8
Neoplasm Metastasis
6
Breast Carcinoma In Situ
5
Breast Neoplasms, Male
4
Breast Diseases
4
Arthralgia
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Advanced Breast Cancer
3
Neoplasms
2
Breast Cancer Metastatic
2
Solid Tumor
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Seizures
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Osteoporosis
1
Obesity
1
Muscle Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Locoregional Recurrence
1
Invasive Breast Cancer
1
Hypogonadism
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Interventions
Cisplatin
21
pembrolizumab
16
Gemcitabine
16
Paclitaxel
15
Radiotherapy
14
Carboplatin
14
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
9
Cetuximab
9
Magnetic Resonance Spectroscopy
8
Radiation
7
padeliporfin
6
Specimen Handling
6
Oxaliplatin
6
Fluorouracil
6
Drug Therapy
6
Docetaxel
6
Capecitabine
6
Bevacizumab
6
anlotinib
5
Nivolumab
5
Irinotecan
5
Erlotinib Hydrochloride
5
Celecoxib
5
poly ICLC
4
fludarabine
4
Standard of Care
4
Sorafenib
4
Leucovorin
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma
×
Anastrozole
×
Clear all
NCT02730923
2024-02-13
VICTORIA
Centre Leon Berard
Phase 1/2
Unknown
72 enrolled